Lymphedema Prevention Program with Body Composition: Practical Insights for Operationalizing a Lymphedema Surveillance Program
Featured Faculty
David Weintritt, MD, FACS – Virginia Cancer Specialists and Founder of the National Breast Center Foundation
Kristin Lupton, PA-C – Virginia Cancer Specialists
Overview
Join our experts! Dr. David Weintritt, MD, FACS and Kristin Lupton, PA-C from Virginia Cancer Specialists will discuss the importance of early detection and intervention for Breast Cancer-Related Lymphedema (BCRL) and provide their insights into operationalizing a Lymphedema Surveillance Program along with Body Composition monitoring for their patients. Hear their expert perspectives on the role of bioimpedance spectroscopy (BIS) technology as well as the latest clinical practice guidelines.
Learning Objectives
- Early Detection & Intervention for Subclinical Lymphedema: Why It’s Important for our Patients
- The Role of Body Composition Monitoring for Survivorship Care
- Operationalizing a Lymphedema Surveillance Program: Best Practices for Implementation & Patient Compliance
Featured Faculty
David Weintritt, MD, FACS
Virginia Cancer Specialists and Founder of the National Breast Center Foundation
Kristin Lupton, PA-C
Virginia Cancer Specialists
Learn More About SOZO®
SOZO uses ImpediMed’s BIS technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. SOZO is non-invasive, fast, and easy to use. Results from the 30-second test* are available immediately providing proactive patient care including early detection of disease progression, treatment monitoring, and patient education.
*As tested on Android
Contact Us